PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-09-07

Date Title Company
07-Sep-2022 Patient preferences surveyed to inform the development of acceptable new treatments University of Birmingham
07-Sep-2022 New imaging technique improves accuracy of diagnosis for the most common skin cancer European Academy of Dermatology and Venereology (EADV) Congress.1
07-Sep-2022 Non-invasive skin immune biomarker test helps predict development of eczema in babies, new study finds European Academy of Dermatology and Venereology (EADV)
07-Sep-2022 Parkinson’s breakthrough can diagnose disease from skin swabs in 3 minutes Journal of the American Chemical Society
07-Sep-2022 Vitamin D deficiency in melanoma patients associated with worse overall survival European Academy of Dermatology and Venereology (EADV) Congress has shown.1
07-Sep-2022 Global Big Data Analytics in healthcare market is expected to reach US$45.64 billion in 2026: Visiongain Reports Ltd Visiongain Reports Limited
07-Sep-2022 Anti-Infective Agents Market Will Grow at a CAGR of 4.3% by 2031: Visiongain Reports Ltd Visiongain Reports Limited
07-Sep-2022 ADOCIA Announces First Cell Therapy Preclinical Proof of Concept of AdoShell® Islets for the Treatment of Type 1 Diabetes Businesswire
07-Sep-2022 mdgroup Chief Operating Officer LaQuinta Jernigan Honoured as one of 100 Most Inspiring People in Life Sciences 2022 mdgroup
07-Sep-2022 iOmx Therapeutics appoints Professor Frances Balkwill to the Scientific Advisory Board iOmx Therapeutics AG
07-Sep-2022 Cellbox Solutions Expands to Israeli Market Via Partnership with BioGate Ltd. B3C newswire
07-Sep-2022 Cannovum AG: Record sales and new customers in the first half of 2022 Cannovum AG
07-Sep-2022  Kirin Holdings: Spoon and Bowl That Enhance the Salty Taste of Low-sodium Food by Approximately 1.5 Times*1 via Stimulation. Businesswire
07-Sep-2022 Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry Gerresheimer AG
07-Sep-2022 Biophytis announces very promising top line results of its phase 2-3 COVA clinical study in COVID-19-related respiratory failure Biophytis
07-Sep-2022 Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall Dermapharm Holding SE
07-Sep-2022 CRISPR therapies Pipeline Assessment – Clinical Trials, Therapeutic Analysis, FDA, EMA, and PMDA Approvals, Emerging Drugs, Growth Prospects, and Key Companies by DelveInsight DelveInsight Business Research
07-Sep-2022 Relief Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference Relief Therapeutics Holding SA